Orient Pharma Co (ROCO:4166) COGS-to-Revenue : 0.49 (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Orient Pharma Co COGS-to-Revenue?

Orient Pharma Co's Cost of Goods Sold for the six months ended in Dec. 2024 was NT$304 Mil. Its Revenue for the six months ended in Dec. 2024 was NT$620 Mil.

Orient Pharma Co's COGS to Revenue for the six months ended in Dec. 2024 was 0.49.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Orient Pharma Co's Gross Margin % for the six months ended in Dec. 2024 was 50.95%.

Orient Pharma Co COGS-to-Revenue Historical Data

The historical data trend for Orient Pharma Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Pharma Co COGS-to-Revenue Chart

Orient Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.82

0.69

0.70

0.47

Orient Pharma Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial															0.77	0.49	0.46	0.44	0.49

Orient Pharma Co COGS-to-Revenue Calculation

Orient Pharma Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	571.257	/	1222.816
	=	0.47

Orient Pharma Co's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	304.029	/	619.838
	=	0.49

Orient Pharma Co (ROCO:4166) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Orient Pharma Co's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	304.029 / 619.838
	=	50.95 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Orient Pharma Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Orient Pharma Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Orient Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Pharma Co Ltd (ROCO:4166) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Kehu 1st Road, Huwei Town, Yunlin County, Central Science Park, Taipei, TWN, 106

Website

http://www.oppharma.com

Orient Pharma Co Ltd develops and manufactures pharmaceuticals. The company uses its platform technologies for the development of specialty pharmaceutical products and is capable of manufacturing products under cGMP. It provides drugs for treating Alzheimer's disease, psychostimulants, and treating Parkinson's disease.

Orient Pharma Co Headlines

No Headlines